BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

KBC Group NV's Holding History (CIK: 0001411133)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 100,000 Value ($000) $0 Avg Close — Range —
Q1 2024
Shares 100,000 Value ($000) $0 Avg Close — Range —
Q4 2023
Shares 100,000 Value ($000) $0 Avg Close — Range —
Q3 2023
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q2 2023
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q1 2023
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q2 2022
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q1 2022
Shares 400,000 Value ($000) $0 Avg Close — Range —
Q4 2021
Shares 200,000 Value ($000) $0 Avg Close — Range —
Q3 2021
Shares 100,000 Value ($000) $103 Avg Close — Range —
Q2 2021
Shares 100,000 Value ($000) $104 Avg Close — Range —
Q1 2021
Shares 200,000 Value ($000) $205 Avg Close — Range —
Q4 2020
Shares 200,000 Value ($000) $214 Avg Close — Range —
Q3 2020
Shares 200,000 Value ($000) $209 Avg Close — Range —
Q2 2020
Shares 400,000 Value ($000) $492 Avg Close — Range —
Q4 2019
Shares 400,000 Value ($000) $424 Avg Close — Range —